首页> 外国专利> Anti-VEGFR2 human antibody for anti-angiogenesis and targeted cancer therapy

Anti-VEGFR2 human antibody for anti-angiogenesis and targeted cancer therapy

机译:抗VEGFR2人类抗体,用于抗血管生成和靶向癌症治疗

摘要

Disclosed is an isolated antibody or antigen-binding fragment thereof having specific binding affinity for an epitope located within domain 1 or domain 3 of human vascular endothelial growth factor receptor 2 (VEGFR2; SEQ ID NO: 74). The epitope within domain 3 of VEGFR2 is located between amino acid residues 250 to 270 of SEQ ID NO: 74. Also disclosed is the use of an antibody or antigen-binding fragment thereof in the manufacture of a medicament that inhibits and / or induces them in a subject in need thereof that inhibits tumor growth, tumor angiogenesis and / or induces cytotoxicity against cancer cells. To do. Also disclosed is a method for detecting the presence of VEGFR2 in tumor vascular endothelial cells or cancer cells of a biological sample.
机译:公开了一种分离的抗体或其抗原结合片段,其对位于人血管内皮生长因子受体2的域1或域3(VEGFR2; SEQ ID NO:74)中的表位具有特异性结合亲和力。 VEGFR2的结构域3内的表位位于SEQ ID NO:74的氨基酸残基250至270之间。还公开了抗体或其抗原结合片段在抑制和/或诱导它们的药物的制备中的用途。在需要其的受试者中抑制肿瘤生长,肿瘤血管生成和/或诱导针对癌细胞的细胞毒性。去做。还公开了一种用于检测生物样品的肿瘤血管内皮细胞或癌细胞中VEGFR2的存在的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号